A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma☆☆☆☆☆☆★★★ Richard M. Nowak, MDemail, Joseph M. Parker, MDcorrespondenceemail, Robert A. Silverman, MDemail, Brian H. Rowe, MD, MScemail, Howard Smi
Nowak RM, Parker JM, Silverman RA, Rowe BH, Smithline H, Khan F, Fiening JP, Kim K, Molfino NA. Am J Emerg Med. 2015 Jan;33(1):14-20. DOI: http://dx.doi.org/10.1016/j.ajem.2014.09.036 Abstract Background Patients with…